Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Karuna Therapeutics

23/02/2023 12:31

* Karuna Therapeutics Inc  KRTX.OQ  reported a quarterly
adjusted
loss of $2.22​​ per share for the quarter ended in December. The
mean expectation of twenty analysts for the quarter was for a
loss of $2.25 per share.
    * Revenue was $5.28 million​; analysts expected $5.88
thousand. 
    * Karuna Therapeutics Inc's reported EPS for the quarter was
a
loss of $2.22​.
    * The mean earnings estimate of analysts had risen by
about 0.1%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Karuna Therapeutics Inc shares had fallen by 3.3% this
quarter.
    * The company reported a quarterly loss of $76.21 million.
    * Wall Street's median 12-month price target for Karuna
Therapeutics Inc is $283.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 20 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
23 at 12:30 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -2.25          -2.22          Beat
 Sep. 30 2022      -2.13          -2.38          Missed
 Jun. 30 2022      -2.09          -2.17          Missed
 Mar. 31 2022      -2.11          -1.95          Beat